Overall survival based on MSI and BRAF mutation status for stage II/III colorectal cancer.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3123324424
